About Robert Berman
Robert Berman is a director at Gilgamesh Pharma.
Experience
This experience comes from Robert Berman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Robert Berman in the role, so the role may have started earlier or lasted longer.
YV
Yale Ventures Current
Executive in Residence
2023 – Present
MI
MindImmune Therapeutics, Inc. Current
Scientific and Medical Advisor
2022 – Present
GP
Gilgamesh Pharmaceuticals Current
Board Member and Strategic Advisor
2021 – Present
OT
Osmol Therapeutics Current
Executive Chairman of the Board
2019 – Present
JR
Jane Coffin Childs Memorial Fund for Medical Research Current
Member Of The Management Board
2019 – Present
BP
Biohaven Pharmaceuticals Current
Co-Founder
2013 – Present
YM
Yale University School of Medicine Current
Professor of Psychiatry (Adjunct)
1990 – Present
Gilgamesh Pharma Inc.
Director
2026 · New York, NY
Develops medicines for people with psychiatric and neurological disorders.
HT
HemoShear Therapeutics
Board Observer
2021 – 2024
SD
Social Capital Suvretta Holdings Company II (NASDAQ:DNAB)
Director
2022 – 2023
BL
Biohaven Medical Services LLC
President
2013 – 2015
BS
Bristol-Myers Squibb
Group Director, Global Clinical Research
2003 – 2013
PF
Pfizer
Associate Director, Clinical Sciences (Early Development)
2000 – 2003
Key Colleagues at Startups
The people Robert Berman works with at each company, as listed on that company's latest Form D.
Gilgamesh Pharma Inc. · Form D, Mar 31, 2026
AK
Amy Kruse
Director
Jonathan Sporn
Founder, CEO and director
PS
Phil Skolnick
Director
ZH
Zia Huque
Director
Andrew Kruegel
Co-Founder, CSO and director